Haploidentical Hematopoietic Cell Transplantation With Post‐Transplant Cyclophosphamide for Pediatric Chronic Active Epstein–Barr Virus Infection
Haplo-HCT with PTCy was safely performed for two pediatric CAEBV patients. Haplo-HCT may be a useful transplant option for CAEBV patients without a matched donor option.
Authors
- Ken‐Ichi Imadome (ORCID: https://orcid.org/0000-0002-1662-4833)
- Kenichi Sakamoto (ORCID: https://orcid.org/0000-0003-1499-538X)
- Kimikazu Matsumoto (ORCID: https://orcid.org/0000-0002-5340-3781)
- Yoshihiro Gocho (ORCID: https://orcid.org/0000-0001-8136-0187)
- Daisuke Tomizawa (ORCID: https://orcid.org/0000-0003-1520-7007)
- Kentaro Fujimori (ORCID: https://orcid.org/0000-0002-6136-4903)
- Takao Deguchi (ORCID: https://orcid.org/0000-0001-9932-4299)
- Masaki Yamada (ORCID: https://orcid.org/0000-0002-3393-6943)
- Shin‐ichi Tsujimoto (ORCID: https://orcid.org/0000-0001-5738-4138)
- Tomoo Osumi (ORCID: https://orcid.org/0000-0001-5536-6788)
- Hirotoshi Sakaguchi (ORCID: https://orcid.org/0000-0003-0236-1187)
- Motohiro Kato (ORCID: https://orcid.org/0000-0001-5145-1774)
- Akihiro Iguchi (ORCID: https://orcid.org/0000-0002-2582-5848)
Institutions
- National Center For Child Health and Development (JP)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1111/petr.70165
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Center for Child Health and Development
- Ministry of Health, Labour and Welfare